AstraZeneca Fails To Block Generic Nexium In Canada
AstraZeneca PLC is likely to face more generic competition over Nexium in Canada now that a federal court has refused to block Apotex Inc. from launching a copycat version of the...To view the full article, register now.
Already a subscriber? Click here to view full article